Stocktoria
Cabaletta Bio, Inc. CABA
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2019-10-25
Cabaletta Bio, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 4,756,219 | $35.6M | 4.73% |
| MILLENNIUM MANAGEMENT LLC | 5,903,281 | $15.9M | 5.88% |
| TWO SIGMA INVESTMENTS, LP | 2,497,917 | $6.7M | 2.49% |
| RENAISSANCE TECHNOLOGIES LLC | 2,036,663 | $5.5M | 2.03% |
| CITADEL ADVISORS LLC | 560,800 | $1.5M | 0.56% |
| Point72 Asset Management, L.P. | 246,615 | $663,394 | 0.25% |
| D. E. Shaw & Co., Inc. | 189,412 | $509,518 | 0.19% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.